The German National Academy of Science Leopoldina accolades Prof. Emmanuelle Charpentier with the Carus-Medal for her exceptional work regarding the CRISPR-Cas9 technology.
Prof. Dr. Emmanuelle Charpentier and her team deciphered the CRISPR-Cas9 mechanism, harnessed as a genome editing technology that allows for the specific and precise modification of the genome.
This development is an important step forward compared to earlier genome-editing tools and provides a huge potential for medical research, specifically for the development of new therapies for serious genetic diseases.
Prof. Dr. Emmanuelle Charpentier holds a professorship at the Hannover Medical School and at the MIMS (Laboratory for Molecular Infection Medicine Sweden), Umeå University and is the head of the department Regulation in Infection Biology at the Helmholtz Center for Infection Research, Braunschweig. In 2015, she was appointed a Director at the Max Planck Institute for Infection Biology in Berlin.
The awarded Carus-Medal honors important scientific achievements of young scientists in one of the research areas represented in the Leopoldina and is associated with the 5000 Euro endowed Carus-Prize.
Together with Prof. Dr. Emmanuelle Charpentier, the chemical physicist Prof. Dr. Hans Jakob Woerner will also be honored.
Leopoldinas press release (only in German)